Stock Price
6.10
Daily Change
-1.03 -14.45%
Monthly
-19.74%
Yearly
39.59%
Q2 Forecast
5.99

Silence Therapeutics reported $-22.49M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
AstraZeneca USD 5.67B 1.29B Mar/2026
Autolus Therapeutics Ltd USD -70.08M 11.23M Sep/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Novartis USD 5.3B 530M Mar/2026
Roche Holding CHF 12.68B 2.36B Jun/2024
Silence Therapeutics USD -22.49M 69K Jun/2025